|
End-of-day quote
Buenos Aires S.E.
29/09/2026
|
5-day change | 1st Jan Change | ||
| 145.50 ARS | -1.69% |
|
-5.52% | -39.50% |
| Market Cap | 6.2B 4.06M 3.59M 3.39M 3.08M 5.77M 390M 5.83M 40.7M 15.69M 199M 15.26M 14.93M 641M | P/E 2024 |
-3.67x | P/E 2025 | -2.23x |
|---|---|---|---|---|---|
| Enterprise Value | 6.93B 4.55M 4.01M 3.8M 3.44M 6.46M 436M 6.52M 45.55M 17.55M 223M 17.07M 16.7M 717M | EV / Sales 2024 |
0.73x | EV / Sales 2025 | 1.71x |
| Free-Float |
19.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -1.69% | ||
| 1 week | -5.52% | ||
| Current month | -10.19% | ||
| 1 month | -10.19% | ||
| 3 months | -11.28% | ||
| 6 months | +7.38% | ||
| Current year | -39.50% |
| 1 week | 143 |  | 150.5 |
| 1 month | 143 | | 165 |
| Current year | 128.5 | | 260 |
| 1 year | 116 | | 357 |
| 3 years | 35 | | 450 |
| 5 years | 9.1 | | 450 |
| 10 years | 4.2 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Oscar Echeverria
DFI | Director of Finance/CFO | - | 30/07/2010 |
Federico Hoffman
CTO | Chief Tech/Sci/R&D Officer | - | - |
Eduardo Busto
ADM | Chief Administrative Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | - | 30/07/2010 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.69% | -5.52% | +9.81% | +303.61% | 4.06M | |
| -1.58% | -3.51% | -50.86% | -59.59% | 29.05B | |
| +0.71% | -1.40% | +15.30% | +101.16% | 11.3B | |
| +0.12% | -4.16% | -14.33% | -2.18% | 3.7B | |
| +0.81% | +2.79% | -0.48% | +20.38% | 2.95B | |
| +1.26% | +1.12% | +26.76% | +45.68% | 1.9B | |
| +0.18% | -2.47% | +20.57% | +21.47% | 1.86B | |
| -0.70% | +0.85% | -9.45% | +177.60% | 1.44B | |
| -0.30% | -4.18% | -21.28% | -9.74% | 1.12B | |
| -0.45% | -1.48% | -6.74% | -41.19% | 1.01B | |
| Average | -0.16% | -1.99% | -3.07% | +55.72% | 5.43B | |
| Weighted average by Cap. | -0.63% | -2.53% | -24.19% | -3.78% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8.27B 5.43M 4.79M 4.53M 4.11M 7.7M 521M 7.78M 54.35M 20.95M 266M 20.38M 19.93M 856M | 6.4B 4.2M 3.71M 3.51M 3.18M 5.96M 403M 6.02M 42.06M 16.21M 206M 15.77M 15.42M 662M |
| Net income | -1.42B -929K -820K -776K -704K -1.32M -89.18M -1.33M -9.31M -3.59M -45.54M -3.49M -3.41M -147M | -4.6B -3.01M -2.66M -2.52M -2.28M -4.28M -289M -4.32M -30.2M -11.64M -148M -11.32M -11.07M -475M |
| Net Debt | 863M 566K 500K 473K 429K 804K 54.31M 811K 5.67M 2.19M 27.73M 2.13M 2.08M 89.25M | 738M 484K 427K 404K 366K 687K 46.42M 694K 4.85M 1.87M 23.7M 1.82M 1.78M 76.28M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/09/26 | ARS 145.50 | -1.69% | 11,660 |
| 28/09/26 | ARS 148.00 | +0.68% | 6,385 |
| 25/09/26 | ARS 147.00 | -1.01% | 2,624 |
| 24/09/26 | ARS 148.50 | -3.88% | 3,840 |
| 23/09/26 | ARS 154.50 | +0.32% | 524 |
- Stock Market
- Stocks
- ROSE Stock
Select your edition
All financial news and data tailored to specific country editions
